AstraZeneca Succeeds in Treating Lupus in Late-stage Study AstraZeneca Succeeds in Treating Lupus in Late-stage Study

AstraZeneca Plc said on Monday its experimental treatment anifrolumab significantly reduced disease activity in patients with systemic lupus erythematosus (SLE) in its late-stage study TULIP-2 study.Reuters Health Information

Source: Medscape Medical News Headlines - November 12, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news